Csenge Advisory Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.61M Sell
24,796
-244
-1% -$45.4K 0.24% 83
2025
Q1
$4.33M Buy
25,040
+2,926
+13% +$506K 0.25% 82
2024
Q4
$3.93M Sell
22,114
-444
-2% -$78.9K 0.21% 93
2024
Q3
$4.38M Sell
22,558
-278
-1% -$54K 0.23% 88
2024
Q2
$3.92M Buy
22,836
+1,222
+6% +$210K 0.22% 89
2024
Q1
$3.94M Sell
21,614
-847
-4% -$154K 0.22% 84
2023
Q4
$3.48M Sell
22,461
-948
-4% -$147K 0.22% 81
2023
Q3
$3.49M Buy
23,409
+963
+4% +$144K 0.24% 80
2023
Q2
$3.02M Buy
22,446
+1,648
+8% +$222K 0.2% 95
2023
Q1
$3.31M Buy
20,798
+770
+4% +$123K 0.24% 82
2022
Q4
$3.24M Buy
20,028
+1,412
+8% +$228K 0.25% 78
2022
Q3
$2.5M Sell
18,616
-833
-4% -$112K 0.21% 92
2022
Q2
$2.98M Sell
19,449
-2,793
-13% -$428K 0.25% 79
2022
Q1
$3.61M Buy
22,242
+2,078
+10% +$337K 0.29% 67
2021
Q4
$2.3M Sell
20,164
-3,355
-14% -$383K 0.21% 92
2021
Q3
$2.57M Buy
23,519
+3,355
+17% +$366K 0.22% 88
2021
Q2
$2.3M Buy
20,164
+3,377
+20% +$386K 0.2% 92
2021
Q1
$1.81M Buy
16,787
+4,358
+35% +$469K 0.18% 93
2020
Q4
$1.33M Buy
12,429
+471
+4% +$50.5K 0.16% 105
2020
Q3
$1.03M Sell
11,958
-2,850
-19% -$245K 0.14% 121
2020
Q2
$1.45M Buy
14,808
+9,919
+203% +$974K 0.21% 91
2020
Q1
$372K Buy
+4,889
New +$372K 0.1% 181
2019
Q1
Sell
-8,774
Closed -$808K 193
2018
Q4
$808K Buy
8,774
+894
+11% +$82.3K 0.3% 74
2018
Q3
$695K Sell
7,880
-5,533
-41% -$488K 0.27% 69
2018
Q2
$1.24M Sell
13,413
-9,291
-41% -$860K 0.46% 52
2018
Q1
$2.15M Sell
22,704
-7,425
-25% -$703K 0.75% 23
2017
Q4
$2.91M Sell
30,129
-425
-1% -$41.1K 1.04% 16
2017
Q3
$2.72M Buy
+30,554
New +$2.72M 1.07% 15